Dr. Young Kwang Chae
Claim this profileNorthwestern University
Area of expertise
Lung Cancer
Young Kwang Chae has run 7 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Young Kwang Chae has run 7 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Northwestern University
Northwestern Medicine Lake Forest Hospital
Clinical Trials Young Kwang Chae is currently running
Pre-Surgery Immunotherapy
for Mesothelioma
This trial tests if giving immunotherapy drugs can better control disease in patients with a specific type of mesothelioma. The drugs help the immune system attack cancer cells, which may stop the cancer from growing and spreading.
Recruiting
1 award
Phase 2
27 criteria
Tepotinib + Ramucirumab
for Lung Cancer
This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non-small cell lung cancer that has spread from where it first started (primary site) to other places in the body (stage IV) or that has come back after a period of improvement (recurrent). Tepotinib is used in patients whose cancer has a mutated (changed) form of a gene called MET. It is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal MET protein that signals tumor cells to multiply. This helps slow or stop the spread of tumor cells. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Giving tepotinib with ramucirumab may lower the chance of the cancer from growing or spreading in patients with stage IV or recurrent non-small cell lung cancer.
Recruiting
1 award
Phase 2
4 criteria
More about Young Kwang Chae
Clinical Trial Related
9 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Young Kwang Chae has experience with
- Pembrolizumab
- Nivolumab
- Ramucirumab
- Talazoparib
- Ipilimumab
- Pemetrexed
Breakdown of trials Young Kwang Chae has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Carcinoma
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Young Kwang Chae specialize in?
Young Kwang Chae focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Young Kwang Chae currently recruiting for clinical trials?
Yes, Young Kwang Chae is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Young Kwang Chae has studied deeply?
Yes, Young Kwang Chae has studied treatments such as Pembrolizumab, Nivolumab, Ramucirumab.
What is the best way to schedule an appointment with Young Kwang Chae?
Apply for one of the trials that Young Kwang Chae is conducting.
What is the office address of Young Kwang Chae?
The office of Young Kwang Chae is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.